Disrupting circadian rhythm of acute myeloid leukemia cells—a possible therapeutic pathway
According to a popular saying, 'timing is everything.' For acute myeloid leukemia (AML), that adage may be true. In a paper published in the April 7 issue of Cell, an international team led by researchers from the Broad Institute ...
Apr 8, 2016
1
77